A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)
Condition: Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma Intervention: Drug: Treatment with Poziotinib Sponsor: Yonsei University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials